Clinical research studyComorbidities of Gout and Hyperuricemia in the US General Population: NHANES 2007-2008
Section snippets
Study Population
The NHANES studies are designed to assess the health and nutritional status of adults and children in the US. These studies are based on a representative sample of the noninstitutionalized US civilian population that is selected using a multistage, stratified sampling design. The survey is unique in that it combines interviews, physical examinations, and various laboratory data. After a home interview, participants were invited to attend examination sessions where blood and urine specimens were
Comorbidities of Gout in the US in 2007-2008
In the NHANES 2007-2008, the mean age was 47 years, 48.2% of subjects were male, and 69.4% were white. Overall, 3.9% of US adults reported a physician or health professional diagnosis of gout. Among these individuals with gout, 74% (6.1 million) had hypertension, 71% (5.5 million) had chronic kidney disease stage ≥2, 53% (4.3 million) were obese, 26% (2.1 million) had diabetes, 24% (2.0 million) had nephrolithiasis, 14% (1.2 million) had myocardial infarction, 11% (0.9 million) had heart
Discussion
In this recent, nationally representative sample of US men and women, we found that the prevalence of comorbidities of gout was substantial. Approximately 74% of US adults with gout had hypertension, 71% had chronic kidney disease stage ≥2, 53% were obese, 26% had diabetes, 24% had nephrolithiasis, 14% had a myocardial infarction, and 11% had heart failure. These prevalences were 2-3 times higher than among those without gout. Correspondingly, we found that with increasing levels of
References (34)
- et al.
Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: the CARDIA studyCoronary Artery Risk Development in Young Adults
Ann Epidemiol
(1998) - et al.
Prevalence of the metabolic syndrome in individuals with hyperuricemia
Am J Med
(2007) - et al.
A high-monounsaturated-fat/low-carbohydrate diet improves peripheral insulin sensitivity in non-insulin-dependent diabetic patients
Metabolism
(1992) - et al.
Effect of insulin on renal sodium and uric acid handling in essential hypertension
Am J Hypertens
(1996) - et al.
Alcohol intake and risk of incident gout in men: a prospective study
Lancet
(2004) - et al.
Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008
Arthritis Rheum
(2011) - et al.
Prevalence of comorbid conditions and prescription medication use among patients with gout and hyperuricemia in a managed care setting
J Clin Rheumatol
(2004) - et al.
Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005
Ann Rheum Dis
(2008) - et al.
Gout epidemiology: results from the UK General Practice Research Database, 1990-1999
Ann Rheum Dis
(2005) - et al.
Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans
Ann Rheum Dis
(2008)
Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey
Arthritis Rheum
Association between serum uric acid and development of type 2 diabetes
Diabetes Care
Pathogenesis of hypertension
Ann Intern Med
Hyperuricemia and coronary heart disease: a systematic review and meta-analysis
Arthritis Care Res (Hoboken)
Hyperuricemia and incident hypertension: a systematic review and meta-analysis
Arthritis Care Res (Hoboken)
Independent impact of gout on the risk of acute myocardial infarction among elderly women: a population-based study
Ann Rheum Dis
The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency
Ann Intern Med
Cited by (484)
Risk of cardiovascular comorbidities before and after the onset of rheumatic diseases
2024, Seminars in Arthritis and RheumatismHyperuricaemia-associated all-cause mortality risk effect is increased by non-impaired kidney function – Is renal hyperuricaemia less dangerous?
2024, European Journal of Internal MedicineGouty tophi of the knee joint: The necessity to exclude malignant tumor
2024, Asian Journal of SurgeryEpidemiology of gout – Global burden of disease research from 1990 to 2019 and future trend predictions
2024, Therapeutic Advances in Endocrinology and Metabolism
Funding: This research was supported by Takeda Pharmaceuticals International, Inc.
Conflict of Interest: Dr Zhu has nothing to disclose. Dr Pandya is an employee of Takeda Pharmaceuticals International, Inc. Dr Choi has received research funding for other projects from Takeda Pharmaceuticals and has served on advisory boards for Takeda Pharmaceuticals, URL Pharma, and Savient Pharmaceuticals.
Authorship: All authors had access to the data and a role in writing the manuscript.